Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-047571

Chief Legal Officer sold 3,264 shares at an average $100.05 ($326,555)

  • Chief Legal Officer acquired 3,264 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lippoldt Darin · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-23 Exercise or conversion : show line 1 in the form +1,664 $32.99 $54,895 21,625 D
2019-08-23 Sale : show line 2 in the form −1,664 $100.09 $166,555 19,961 D
2019-08-27 Exercise or conversion : show line 3 in the form +1,600 $32.99 $52,784 21,561 D
2019-08-27 Sale : show line 4 in the form −1,600 $100.00 $160,000 19,961 D
Open-market sales · 3,264 sh · avg $100.05 · $326,555

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2019-08-23 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option −1,664 $32.99 $54,895 $32.99 2025-02-03 1,664 14,961 D
2019-08-27 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option −1,600 $32.99 $52,784 $32.99 2025-02-03 1,600 13,361 D
Loading xslF345X03/doc4.xml…